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Abstract 
Lung cancers seem to be in­
creasting in their incidence in our 
country a study had been made en 50 
patients with caracinoma of the luna I;;) 
at marjan teaching hospital in babil. 
The age groups mestly affected were 
between (43-87) years and a mean 
age of 60.5 year. Male to female re­
atie of (6.1:1) 75% of the patients 
were advanced at their presentation 
and 80% were heavy smokers. 
Squmous-cell tyo histology was 
the most common type, Bronchosco­
py and sputum cytology were the 
main methods of diagnosis in our pa­
tients. All patients with squamous 
cell-type carcinoma had recieved ra­
diotherapy and/or chemotherapy. 
Introduction 
Lung cancer is the leading cause 
of death due to malignancy in both 
men and women, and death rate con­
tinues to rise in non-smaIl-cell lung 
ca and in developed countries it is 
particularly true in women where 
lung cancer death rate exceed that of 
breast ca.*(1,2,3) in 1987 it was esti­
mated that lung ca. would kill 
136.000 presons in U.S. * (4,5), 
Smoking is amajor health haz­
ard and is the dominant cause of 
lung cancer and COAD 80-90% of 
cases of lung ca. may be directly 
linked to active ciggerates smoking 
(.6) In develobed countries smoking 
is responsible for more than 30% of 
all cancer deaths including ca.-lung, 
the smoking habits increased among 
females and the prev lance rate of 
smoking habits among female in 
Baghdad city was 13.3% and it is in­
creased as ago progressed (7 ,8). 
The 5 year survival rate of pa­
tients with Ca. bronchus only is (8­
12 %), this reflect the fact that dis­
ease is advanced in most of the pa­
tients when I st. detected, and further 
more screening regimen does not al­
ter. Mortality rate fromlung Ca. nor 
offecial recommendations available 
for screening patients with lung 
Ca(O,O). We undertooka study on 50 
patients with lung Ca. admitted to 
Merjan Hospital in Babylon Jan. 
1992 to Dec. 1993 in oreder to show 
the varicus clinical and some epi­
demiologig as pects of Ca.-bronchus. 
Patients and Methods 
50 Patients admitted to Merjan 
Hospital with diagnosis of Ca.­
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bronchus from Jan 1992 to Dec. 
1993. All the patients were clinically 
assessed and by CXR , U/S and bone 
survey if indicated blood picture, 
sputum cytology and Bronchoscopy 
done, and one patients had mediasti­
noscopy for the diagnosis. Pleural 
fluid aspiration, cytology and/or bi­
opsy done in patients whom they 
have pleural effusion. The main 
methods for diagnosis are sputum 
cytology and bronchoscopy, one pa­
tients had fine needle caspiration for 
the diagnosis. 
Results 
Age incidance the age of the pa­
tients were between (43-87) year a 
mean of (60.5) year. 
Sex incidence: 43 were males 
and 7 were females, a ratio of 
(6.1:1) 16 out of 50 patients were 
(Framer) and majority of these pa­
tients were heavy smoker over 30 
years duration, a number stop their 
smoking habits, few months prior 
presentation and as they had become 
symptomatic. 
Symptomatology were de­
scribed in table No.1 with compari­
son of the symptoms & manifestation 
with AI-Alusis series (11,12). 
Duration of the syptoms befor 
the dx is raning from (1 month­
2year) and table 2 demonstrate the 
natural history of lung Ca. 
The main methods of diagnosis 
are sputum cytology and/or bron­
choscopy, and sputum cytology done 
in 18 patients and 6 had positive re­
sult for cytology and in a 
study(13,14) done 102 consequetive 
patients with histologically proved 
lung Ca. three samples were exam­
ined cytology, the overall sensisity 
of sputum cytology detecting malig­
nant cells wer 0.8 with an accuracy 
of 77.4%, and table No.3 shows the 
main methods and their +ve results. 
The commonest histologic type 
is squamous cell Ca. and table No.4 
shows the percentage of histologic 
type and table No.5 shows histologic 
classification and most frequent his­
tology in Iraq, registered by Iraqi 
Cancer registry (1986-1988)(15), 
The most common sit of site of 
affection in bronchogenic Ca. is the 
right lung making about 30 out of 50 
patients. 
One patient had lung resection 
at her presentation and 2 years lat­
ers, she develops recurrance of 
symptoms. 
Discussion 
Lung cancer incidence is con­
stantly and progressively increasing 
in every country. At the turn of the 
century only 1 % of all deaths were 
due to this disease & currently the 
figure has reahed 2.3%(16,17,18). 
Tobacco consumption is rising by 
2.1 % a year in the developing 
world(18,19). By an observation it 
seem that smoking habits is high 
among farmers, we had noticed that 
about 36% of our patients were far­
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mars, this is in contra distinction to a 
study(18,19), done before which 
showed that 87% of the patients 
were from large cities than in rural 
areas and this need effective anti­
smoking education and at titude to 
control this health haz­
ard(20,21,22,23) . 
It seems that the trend of adeno 
carcinoma of the lung preponde­
ronce is not represented in our stud­
ied patients, in addition all the cases 
of adenocarcinoma of the bronchus 
recorded were smoker. We had no­
ticed that the patients whom they 
present with advanced stage and met­
asttasis have high ESR over 115. 
Also bone pain and boney metastasis 
or secondaries noticed in 8% of the 
studied patients, no predictive value 
or biohemical test was made in our 
patients, however, it has beeen sug­
gested, but not clearly proved that 
normal LDH level are predictive of 
negative bone marrow examinationin 
pOatients with small-cell-cancer(24). 
No other risk factors a part 
from smoking were indentified in 
ourpatients and it has been suggested 
that exposure to Radon in houses and 
indoor and outdoor exposure has 
synergistic action with smoking(2S). 
No familial incidence were ob­
served in our studied patients, and it 
has been cocluded that loss of short 
arm of chromosome No. 3 is a 
change found consistently in 
smallOcelllung Ca. and occassionally 
in non-small cell lung Ca.(26). As 5 
year survivaly rate of lung cancer is 
(8-12%), making lung cancer a seri­
ous health problem and this in need 
for early detection and diagnosis and 
control, though provision of screen­
ing programme for high risk groups 
to detect early stage lung cancer does 
not alter mortality from lung cancer 
nor official recommendation was 
well documented. 
We belive that mang social, ec­
onomic and many other non-medical 
factors might infleunce the treatment 
of person given a diagnosis of non­
small cell lung cancer especially 
when optimal therapy is uncer­
tain(27), and this is especially during 
our present critical circumstances of 
shortage in medical & non-medical 
means. 
The present value combination 
C.T. in prolonging survival of pa­
tients with wide-spread non-small­
cell lung cancer is unceratain, and 
some recent randomised trials have 
concluded that such treatment is ben­
ficial (28,29) whereas trials have 
found that the outcome of cytotoxics 
drug treatment to be no better than 
best supportive caro(30). 
In conclusion Broncho genic 
carcinoma is still the most common 
lung cancer in our country smoking 
is the major health hazard for the 
development of this type of cancer 
and any attempts to reduce the inci­
dence of this cancer must be 1ST, di­
rected at the reduction of this abnor­
mal habit among the population 
abnormal. 
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Table -1: Percentage of principle manifestations of lung 
Cancer in two series 
Manifestation Present Series 
% 
AI-Alusis series 
% 
Cough 96 91 
Chest and Shoulder Pain 54 84 
-SOB (Short tness of breath) 36 81 
* Haemoptysis 24 68 
* Clubbing 20 61 
Hoarsness 10 7 
*Weight loss 28 88 
Anorexia 20 -
*Hepatomegaly 20 56 
PI. effusion 16 21 
Lymphadenopathy 8 32 
Bones pain and bone secondaries 8 -
SVCO (superior vena cara obstruction) 6 3 
Dysphagia 2 3.5 
Joints poin (HPOA) (Hyper trophic pul­ 4 -
monary osteo or thropathy) 
HPOA (Hyper trophic pulmonary osteo or thropathy) 
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Table -2: Lung Cancer 1993 Statistics 

Male Female 
Estimated incidence 100.000 70.000 
Estimated deaths 93.000 56.000 
5 Y.S. of all stage: 

(Five years survival) of all stage 

1960 - 1963 White 8% 
Black 5% 
1683 - 1988 White 13% 
11%Black 
Natural history of Lung Ca. 
Lesion (1 cm-60% of eventual growth) symptoms 
Originates (years) 20 months 
2 months 
1 month Diagnosis ____ initial clinical 
visit 
* 5 Y.S. = five years survival 
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Table -3: Methods of diagnosis 

Positive results No. done Procedure 
16 6Sputum Cytology 
I 20Pronchoscopy 21 
1 1Mediastinoscopy 
8 6Pleural fluid study 
11*FNA 
* FNA ( fine needle aspiration) 
Table (4) Percentage of histologic type 
Histology No. done Positive results 
Squamous Carcinoma 
Adeno - Cacinoma 
Small - Cell type 
Undifferentiated 
26 
18 
5 
1 
52 
36 
10 
2 
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Table -5: Most Frequent Histology (Results of Iraq 

Cancer registry 1986 - 1988) 

Histology (Ca) No Positive results 
Squamous 751 39.6 
Small Cell 265 14 
Adenocarcinoma 230 12.1 
U ndifferen ti ated 156 8.2 
Large Cell 88 4.6 
Malignmt Cells (cytology) 33 1.7 
Pan coast 22 1.2 
Carcinoid 10 0.5 
Other Sarcama 8 0.4 
Other 12 0.6 
No histology 323 17 
Histologically Verified 
Cases 
1575 83.0 
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